详情页 - 河北大学附属医院知识库

资源类型：

文章类型：

作者：

Qu, Wang[1,2,3,4,5,6,7,8,9,10] * ; Liu, Zimin[1,2,3,4,5,6,7,8,9,10] ; Zhu, Liangjun[1,2,3,4,5,6,7,8,9,10] ; Chen, Xiaobing[1,2,3,4,5,6,7,8,9,10] ; Liu, Bo[1,2,3,4,5,6,7,8,9,10] ; Zhao, Yun-Bo[1,2,3,4,5,6,7,8,9,10] ; Yan, Hao[1,2,3,4,5,6,7,8,9,10] ; Qu, Xiujuan[1,2,3,4,5,6,7,8,9,10] ; Li, Shengmian[1,2,3,4,5,6,7,8,9,10] ; Zang, Ai-Min[1,2,3,4,5,6,7,8,9,10]

; Jiang, Zhichao[1,2,3,4,5,6,7,8,9,10] ; Sun, Yongkun[1,2,3,4,5,6,7,8,9,10] ; Zhou, Ai-Ping[1,2,3,4,5,6,7,8,9,10] ;

机构： [1]Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China [2]Department of Medical Oncology, Affiliated Hospital of Qingdao University, Qingdao, China [3]Department of Medical Oncology, Jiangsu Cancer Hospital, Nanjing, China [4]Department of Medical Oncology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China [5]Department of Medical Oncology, Shandong Cancer Hospital, Jinan, China [6]Department of Oncology, Beijing Hospital, National Center of Gerontology, Beijing, China [7]Department of Oncology, Institute of Integrative Oncology, Tianjin Union Medical Center, Tianjin, China [8]Department of Oncology, The First Hospital of China Medical University, Shenyang, China [9]Department of Gastroenterology and Hepatology, Fourth Hospital of Hebei Medical University, Shijiazhuang, China [10]Department of Oncology, Affiliated Hospital of Hebei University, Baoding, China

出处：

ISSN：

语种：

WOS：

中科院(CAS)分区：

出版当年[2025]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

JCR分区：

出版当年[2023]版：

Q1 ONCOLOGY

最新[2023]版：

Q1 ONCOLOGY

第一作者：

第一作者机构： [1]Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China [2]Department of Medical Oncology, Affiliated Hospital of Qingdao University, Qingdao, China [3]Department of Medical Oncology, Jiangsu Cancer Hospital, Nanjing, China [4]Department of Medical Oncology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China [5]Department of Medical Oncology, Shandong Cancer Hospital, Jinan, China [6]Department of Oncology, Beijing Hospital, National Center of Gerontology, Beijing, China [7]Department of Oncology, Institute of Integrative Oncology, Tianjin Union Medical Center, Tianjin, China [8]Department of Oncology, The First Hospital of China Medical University, Shenyang, China [9]Department of Gastroenterology and Hepatology, Fourth Hospital of Hebei Medical University, Shijiazhuang, China [10]Department of Oncology, Affiliated Hospital of Hebei University, Baoding, China

推荐引用方式(GB/T 7714)：

APA：

MLA：

Treatment modalities of regorafenib and survival in metastatic colorectal (mCRC) patients: A real-world multicenter retrospective study

文献详情